Duration of Untreated, Uncomplicated Chlamydia trachomatis Genital Infection and Factors Associated with Chlamydia Resolution: A Review of Human Studies
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
The majority of Chlamydia trachomatis genital infections in humans are asymptomatic and without clinical evidence of complications at the time of diagnosis. The natural history of chlamydial infection in humans, including the duration of infection and factors influencing resolution of infection, is not yet completely understood. This is in part attributable to the inherent challenges and ethical considerations in studying untreated chlamydia in humans. An improved understanding of the natural history of chlamydia in humans has implications for chlamydia screening and treatment recommendations. In April 2008, the Centers for Disease Control and Prevention convened an advisory group for the Chlamydia Immunology and Control Expert Advisory Meeting, in which studies related to chlamydia natural history, pathogenesis, and immunobiology were reviewed and gaps in our knowledge that would have implications for prevention and control of C. trachomatis infection were identified. This article summarizes the key questions posed and the evidence reviewed on the duration of untreated, uncomplicated genital chlamydial infection in humans and the factors associated with chlamydia resolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sexually transmitted disease surveillance
O'Connor, B. H., Tillett, H., Berrie, J. R. H., Emslie, J. A. N., & Adler, M. W. (1982) · BMJ · doi:10.1136/bmj.284.6318.825-d · Cited by 2,185
Sexually transmitted disease surveillance.
Schofield, C. B. (1982) · BMJ · doi:10.1136/bmj.284.6318.825-c · Cited by 1,869
Risk of Sequelae after Chlamydia trachomatis Genital Infection in Women
Haggerty, C. L., Gottlieb, S. L., Taylor, B. D., Low, N., Xu, F., & Ness, R. B. (2010) · The Journal of Infectious Diseases · doi:10.1086/652395 · Cited by 657 · cited 1×
“Animal and in vitro studies of the duration of untreated chlamydial infection that were reviewed at the advisory meeting are discussed elsewhere in this supplement [3, 4], as are human studies related to chlamydia pathogenesis and protective immunity [5–7].”
BackgroundPathogenesis of Genital Tract Disease Due to Chlamydia trachomatis
Darville, T., & Hiltke, T. J. (2010) · The Journal of Infectious Diseases · doi:10.1086/652397 · Cited by 334 · cited 1×
“Animal and in vitro studies of the duration of untreated chlamydial infection that were reviewed at the advisory meeting are discussed elsewhere in this supplement [3, 4], as are human studies related to chlamydia pathogenesis and protective immunity [5–7].”
BackgroundChlamydia trachomatis Persistence In Vitro: An Overview
Wyrick, P. B. (2010) · The Journal of Infectious Diseases · doi:10.1086/652394 · Cited by 257 · cited 1×
“Animal and in vitro studies of the duration of untreated chlamydial infection that were reviewed at the advisory meeting are discussed elsewhere in this supplement [3, 4], as are human studies related to chlamydia pathogenesis and protective immunity [5–7].”
BackgroundMolano, M., Meijer, C. J. L. M., Weiderpass, E., Arslan, A., Posso, H., Franceschi, S., Ronderos, M., Muñoz, N., & van den Brule, A. J. C. (2005) · The Journal of Infectious Diseases · doi:10.1086/428287 · Cited by 244
Morré, S. A., Van Den Brule, A. J. C., Rozendaal, L., Boeke, A. J. P., Voorhorst, F. J., De Blok, S., & Meijer, C. J. L. M. (2002) · International Journal of STD & AIDS · doi:10.1258/095646202762226092 · Cited by 224 · cited 5×
“Morré et al [17] reported that female participants infected with C. trachomatis OmpA type E were more likely to have chlamydia persistence after 1 year of follow-up than were those infected with the other genotypes.”
BackgroundInfluentialEvidence for Long‐Term Cervical Persistence of Chlamydia trachomatis by omp1 Genotyping
Dean, D., Suchland, R. J., & Stamm, W. E. (2000) · The Journal of Infectious Diseases · doi:10.1086/315778 · Cited by 193 · cited 2×
“Dean et al [29] described several female participants with 3 consecutive, uncomplicated genital chlamydial infections with the same OmpA genotype (identical ompA gene sequences or only 1 or 2 amino acid changes) during 12 years of followup at a Seattle STD clinic and suggested that this was evidence for persistence, a…”
BackgroundFifteen-Month Follow-up Study of Women Infected with Chlamydia trachomatis
McCormack, W. M., Alpert, S., McComb, D. E., Nichols, R. L., Semine, D. Z., & Zinner, S. H. (1979) · New England Journal of Medicine · doi:10.1056/nejm197901183000305 · Cited by 185
Geisler, W. M., Wang, C., Morrison, S. G., Black, C. M., Bandea, C. I., & Hook, E. W. (2008) · Sexually Transmitted Diseases · doi:10.1097/olq.0b013e318151497d · Cited by 166 · cited 7×
“[9] Prospective; 2002–2006; screening C.”
BackgroundResultInfluentialSelf-citationProtective Immunity to Chlamydia trachomatis Genital Infection: Evidence from Human Studies
Batteiger, B. E., Xu, F., Johnson, R. E., & Rekart, M. L. (2010) · The Journal of Infectious Diseases · doi:10.1086/652400 · Cited by 141 · cited 1×
“Animal and in vitro studies of the duration of untreated chlamydial infection that were reviewed at the advisory meeting are discussed elsewhere in this supplement [3, 4], as are human studies related to chlamydia pathogenesis and protective immunity [5–7].”
BackgroundSpontaneous Clearance of Chlamydia trachomatis Infection in Untreated Patients
PARKS, K. S., Dixon, P. B., Richey, C. M., & Hook, E. W. (1997) · Sexually Transmitted Diseases · doi:10.1097/00007435-199704000-00008 · Cited by 121 · cited 5×
“S108 • JID 2010:201 (Suppl 2) • Geisler mydia resolution in 2 studies [8, 13], but this association was not consistently found in all studies reviewed.”
BackgroundResultInfluentialJoyner, J. L., Douglas, J. M., FOSTER, M., & Judson, F. N. (2002) · Sexually Transmitted Diseases · doi:10.1097/00007435-200204000-00002 · Cited by 89 · cited 3×
“[10] Retrospective; 1996; screening C.”
BackgroundGomes, J. P., Borrego, M. J., Atik, B., Santo, I., Azevedo, J., Sá, A. B. D., Nogueira, P., & Dean, D. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.05.014 · Cited by 80 · cited 2×
“A study by Gomes et al [30] evaluated the relationship of OmpA genotype with another biological characteristic of C. trachomatis infection, the infectious load (a quantitative measure of organism burden and presumably a surrogate for chlamydia replication), and how genotype correlated with genital chlamydial infection…”
BackgroundGhanem, K. G., Shah, N. G., Klein, R. S., Mayer, K. H., Sobel, J. D., Warren, D. L., Jamieson, D. J., Duerr, A. C., & Rompalo, A. (2005) · The Journal of Infectious Diseases · doi:10.1086/427190 · Cited by 73 · cited 2×
“[24] Retrospective; host immune responses measured in participants tested for C.”
BackgroundConcordance of chlamydia trachomatis infections within sexual partnerships
Rogers, S., Miller, W. C., Turner, C. F., Ellen, J. M., Zenilman, J. M., Rothman, R. E., Villarroel, M. A., Al‐Tayyib, A., Leone, P. A., Gaydos, C. A., et al. (2007) · Sexually Transmitted Infections · doi:10.1136/sti.2007.027029 · Cited by 49 · cited 1×
“[11] Prospective; 2002–2005; screening C.”
Geisler, W. M., Yu, S.-Y., & Hook, E. W. (2005) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000175390.45315.a1 · Cited by 45 · cited 2×
“per oil immersion field [23]; (4) PMN cell counts in cervico-”
BackgroundSelf-citationSpontaneous Resolution of Asymptomatic Chlamydia trachomatis in Pregnancy
Sheffield, J. S., Andrews, W., Klebanoff, M. A., MacPherson, C., Carey, J. C., Ernest, J. M., Wapner, R. J., Trout, W., Moawad, A., Miodovnik, M., et al. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000153533.13658.c2 · Cited by 36 · cited 5×
“S108 • JID 2010:201 (Suppl 2) • Geisler mydia resolution in 2 studies [8, 13], but this association was not consistently found in all studies reviewed.”
BackgroundResultInfluentialHu, D., Hook, E. W., & Goldie, S. J. (2006) · Sexually Transmitted Diseases · doi:10.1097/01.olq.0000200577.46261.b0 · Cited by 29 · cited 1×
“of screening strategy cost-effectiveness [2].”
van Valkengoed, I. G. M., Morré, S. A., van den Brule, A. J. C., Meijer, C. J. L. M., Bouter, L. M., van Eijk, J. T. M., & Boeke, A. J. P. (2002) · Europe PMC (PubMed Central) · Cited by 29
Cited by
Price, M. J., Ades, A., Soldan, K., Welton, N. J., Macleod, J., Simms, I., DeAngelis, D., Turner, K. M., & Horner, P. J. (2016) · Health Technology Assessment · doi:10.3310/hta20220 · Cited by 494
“Although studies of the duration of asymptomatic infection have produced a wide range of estimates – between 1 and 18 months (see Chapter 4) – it is evident that the infection can clear spontaneously in the absence of treatment as a consequence of the adaptive and innate immune responses.(38,74)”
Background2015 European guideline on the management of Chlamydia trachomatis infections
Lanjouw, E., Ouburg, S., de Vries, H., Stary, A., Radcliffe, K., & Unemo, M. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462415618837 · Cited by 328
Chlamydia trachomatis: the Persistent Pathogen
Witkin, S. S., Minis, E., Athanasiou, A., Leizer, J., & Linhares, I. M. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00203-17 · Cited by 206
Toward global prevention of sexually transmitted infections (STIs): The need for STI vaccines
Gottlieb, S. L., Low, N., Newman, L. M., Bolan, G., Kamb, M., & Broutet, N. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.07.087 · Cited by 162
Chlamydia trachomatis infection in African American women who exclusively have sex with women
Muzny, C. A., Kapil, R., Austin, E. L., Brown, L., Hook, E. W., & Geisler, W. M. (2016) · International Journal of STD & AIDS · doi:10.1177/0956462415604092 · Cited by 9
“In addition, because of the asymptomatic nature of most CT infections, they often go undetected and may be treated through receipt of antibiotics given for other reasons or resolve spontaneously.(6) Thus, data on CT risk among WSW based on self-report and/or nucleic acid amplification (NAAT) testing for current genita…”
Background
Metadata
- Authors
- Geisler, W. M.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-06-15
- Volume
- 201
- Issue
- S2
- Pages
- 104-113
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2018311659
- Cited by
- 194
- References
- 20
- FWCI
- 12.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.